Authors

• Dung‐Tsa Chen (ORCID: https://orcid.org/0000-0001-5026-415X)
• John M. Kirkwood (ORCID: https://orcid.org/0000-0002-3570-4476)
• Issam El Naqa (ORCID: https://orcid.org/0000-0001-6023-1132)
• Arivarasan Karunamurthy (ORCID: https://orcid.org/0000-0002-5739-4923)
• Ahmad A. Tarhini (ORCID: https://orcid.org/0000-0002-3193-9702)
• Lisa H. Butterfield (ORCID: https://orcid.org/0000-0002-3439-9844)
• Timothy I. Shaw (ORCID: https://orcid.org/0000-0002-9316-1924)
• Patrick Hwu (ORCID: https://orcid.org/0000-0002-8293-1313)
• Alyssa Obermayer (ORCID: https://orcid.org/0000-0002-7333-973X)
• Sandra J. Lee (ORCID: https://orcid.org/0000-0002-8626-639X)
• Vernon K. Sondak (ORCID: https://orcid.org/0000-0003-1090-484X)
• William A. LaFramboise (ORCID: https://orcid.org/0000-0002-6024-810X)
• Islam Eljilany (ORCID: https://orcid.org/0000-0001-6387-5419)
• Walter J. Storkus (ORCID: https://orcid.org/0000-0001-8961-4444)
• F. Stephen Hodi (ORCID: https://orcid.org/0000-0001-6825-091X)
• HOWARD Z. STREICHER (ORCID: https://orcid.org/0000-0003-3683-9804)

Institutions

• Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
• Allegheny Health Network (US)
• University of Pittsburgh (US)
• University of California, San Francisco (US)
• Moffitt Cancer Center (US)
• Applied Science Laboratories (United States) (US)
• Dana-Farber Cancer Institute (US)
• UPMC Hillman Cancer Center (US)
• National Cancer Institute (MY)
• University of Pittsburgh Medical Center (US)
• National Cancer Institute (US)

Publication Details

Journal

Clinical Cancer Research

Published

2025-05-20

DOI

https://doi.org/10.1158/1078-0432.ccr-24-3980

Citations

1

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

1.05

Funders

• University of Pittsburgh
• Moffitt Cancer Center